Hyundai Bioscience Co. Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: -0.052x

Hyundai Bioscience Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Hyundai Bioscience Co. Ltd (048410) has a cash flow conversion efficiency ratio of -0.052x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩-5.41 Billion ≈ $-3.66 Million USD) by net assets (₩103.31 Billion ≈ $70.01 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Hyundai Bioscience Co. Ltd (2008–2025)

Cash flow conversion efficiency of Hyundai Bioscience Co. Ltd from 2008 to 2025. This chart illustrates how Hyundai Bioscience Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View 048410 live share price for real-time trading data and today's change.

Hyundai Bioscience Co. Ltd Cash Flow Conversion Ratio Explained

Hyundai Bioscience Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Hyundai Bioscience Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Hyundai Bioscience Co. Ltd ranked by their cash flow conversion efficiency. Also see Hyundai Bioscience Co. Ltd (048410) market capitalisation for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Yibin Paper Industry Co Ltd SHG:600793	0.088x
GSR III Acquisition Corp. Ordinary Shares NASDAQ:GSRT	-0.002x
Muang Thai Insurance Public Company Limited BK:MTI	0.031x
Twin Disc Incorporated NASDAQ:TWIN	0.093x
Wuhan Ligong Guangke Co Ltd SHE:300557	0.008x
Crescent Capital BDC Inc NASDAQ:CCAP	0.022x
InPlay Oil Corp TO:IPO	0.076x
PNC Infratech Limited NSE:PNCINFRA	0.615x

Annual Cash Flow Conversion Efficiency for Hyundai Bioscience Co. Ltd (2008–2025)

The table below shows the annual cash flow conversion efficiency of Hyundai Bioscience Co. Ltd from 2008 to 2025. Review 048410 free cash flow to operating cash ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩110.73 Billion ≈ $75.04 Million	₩-17.05 Billion ≈ $-11.55 Million	-0.154x	-369.06%
2024-12-31	₩39.44 Billion ≈ $26.73 Million	₩2.26 Billion ≈ $1.53 Million	0.057x	+143.12%
2023-12-31	₩45.27 Billion ≈ $30.68 Million	₩-6.01 Billion ≈ $-4.07 Million	-0.133x	+53.28%
2022-12-31	₩58.24 Billion ≈ $39.47 Million	₩-16.54 Billion ≈ $-11.21 Million	-0.284x	-3148.24%
2021-12-31	₩61.57 Billion ≈ $41.73 Million	₩-538.48 Million ≈ $-364.92K	-0.009x	-105.97%
2020-12-31	₩51.22 Billion ≈ $34.71 Million	₩7.50 Billion ≈ $5.08 Million	0.146x	-25.02%
2019-12-31	₩46.99 Billion ≈ $31.84 Million	₩9.18 Billion ≈ $6.22 Million	0.195x	+58.00%
2018-12-31	₩40.48 Billion ≈ $27.44 Million	₩5.01 Billion ≈ $3.39 Million	0.124x	+203.33%
2017-12-31	₩30.89 Billion ≈ $20.93 Million	₩-3.70 Billion ≈ $-2.50 Million	-0.120x	+49.76%
2016-12-31	₩18.21 Billion ≈ $12.34 Million	₩-4.34 Billion ≈ $-2.94 Million	-0.238x	-6808.19%
2015-12-31	₩24.60 Billion ≈ $16.67 Million	₩87.36 Million ≈ $59.20K	0.004x	-93.48%
2014-12-31	₩22.49 Billion ≈ $15.24 Million	₩1.22 Billion ≈ $829.60K	0.054x	-80.56%
2011-12-31	₩14.17 Billion ≈ $9.61 Million	₩3.97 Billion ≈ $2.69 Million	0.280x	+35.95%
2008-12-31	₩50.36 Billion ≈ $34.13 Million	₩10.37 Billion ≈ $7.03 Million	0.206x	--

About Hyundai Bioscience Co. Ltd

KQ:048410 Korea Biotechnology

Market Cap

$356.42 Million

₩525.94 Billion KRW

Market Cap Rank

#13722 Global

#407 in Korea

Share Price

₩5450.00

Change (1 day)

+4.21%

52-Week Range

₩4595.00 - ₩20000.00

All Time High

₩54700.00